Pathology is a crucial field in medicine that involves the study of diseases and their effects on the human body. Pathologists are responsible for diagnosing diseases by examining tissue samples and other bodily fluids. However, this process can be time-consuming and prone to errors, which can lead to misdiagnosis and delayed treatment. To address these challenges, PathAI, a Boston-based company, is using artificial intelligence (AI) to improve the accuracy and efficiency of pathology image analysis.
PathAI was founded in 2016 by a team of researchers from Harvard Medical School and Massachusetts Institute of Technology (MIT). The company’s mission is to transform pathology by leveraging AI and machine learning to analyze pathology images and provide more accurate diagnoses.